SCHEDULE 13G/A: BlackRock Discloses 7.6% Passive Stake in Labcorp Holdings Inc.

Sentiment:

Beneficial Ownership Report


BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.6% beneficial ownership stake in Labcorp Holdings Inc. as of March 31, 2025.

Summary

  • BlackRock, Inc. reported beneficial ownership of 6,331,017 shares of Common Stock in LABCORP HOLDINGS INC.
  • This ownership represents 7.6% of the class of securities.
  • BlackRock, Inc. holds sole voting power over 5,749,964 shares.
  • BlackRock, Inc. holds sole dispositive power over 6,331,017 shares.
  • No shared voting or dispositive power was reported.
  • The filing is an Amendment No. 17 to Schedule 13G, indicating ongoing disclosure of a passive investment.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing (Schedule 13G) disclosing beneficial ownership. It is purely factual and does not contain subjective language or forward-looking statements that would indicate a positive or negative sentiment. It is neutral.

Future Outlook

NA

Management Comments

  • "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยงยง 240.14a-11."

Industry Context

This filing reflects a routine disclosure by a major institutional asset manager, BlackRock, regarding its passive investment in a publicly traded healthcare diagnostics company, Labcorp Holdings Inc. Such disclosures are common and indicate a significant, but non-controlling, stake held for investment purposes.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant institutional holder's stake, confirming a passive investment approach by BlackRock.

Key Dates

DateDescription
2025-01-21Date of execution for the Power of Attorney document.
2025-03-31Date of event which requires filing of this statement (reporting period end date).
2025-04-24Date of signature for the Schedule 13G filing.

Keywords

BlackRock, Labcorp Holdings Inc., Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Management, Asset Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.